Innodal develops and produces antimicrobials for various sectors and offers innovative solutions to inhibit microbiological pathogens.
Innodal has raised $944K in total funding. The most recent round was Grant. The last funding was announced in May 2022.
Innodal's investors include Canadian Food Innovation Network.
Innodal is headquartered in Lévis, Canada.
Innodal develops and produces antimicrobials for various sectors and offers innovative solutions to inhibit microbiological pathogens.
Innodal is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Innodal — Funding & Investors." VCBacked, May 31, 2022, https://www.vcbacked.co/company/innodal. Accessed August 14, 2026.
VCBacked. (2022). Innodal — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/innodal
{{cite web |title=Innodal — Funding & Investors |url=https://www.vcbacked.co/company/innodal |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated